Our research
Learn about our research and our research projects here
ALS (amyotrophic lateral sclerosis) is a fatal neuromuscular disease that is characterized by a degeneration of upper and lower motorneurons. The patients experience a weakness usually starting in the upper or lower extremities spreading to other regions weakening both speech and swallowing. Besides the muscle weakness, cognitive dysfunction and behavioral changes are seen in about 50% of the patients and some develop fulminant frontotemporal dementia.
Learn about our research and our research projects here
ALS Clinical Research Group´s webpage.
The group strives to integrate ALS research and care by conducting clinical research.
On March 20th, Caroline Ingre received a grant from the Royal foundation, supporting and acknowledging ALS research conducted in Sweden. A big celebration for ALS Clinical Research Group, active in clinical trials, partnering with TRICALS, and also conducting pre-clinical and clinical research projects at the Karolinska Institutet and Karolinska University Hospital.
Neuroförbundet distributes close to SEK 14 million to three ALS research projects. The research should contribute to better nursing, new medicines and precision medicines.
Title: Biomarkers and psychological stress in amyotrophic lateral sclerosis